Investors
Need clarity.
They need to understand the opportunity, the competitive advantage and the potential for growth.
Scientific communication for medtech startups
Blenti is a new independent studio built to turn complex biotech into clear, credible communication for investors, partners and customers.
We are bringing scientific depth, communication strategy and design together to shape how biotech startups explain their technology, express their identity and connect with the right audience.
Our founding pilot
Before launching our full services, we are partnering with five small biotech and life-science startups. Each selected team will receive a focused communication diagnosis, a refined core narrative and a practical roadmap for its next communication priorities, free of charge.
The Communication Challenge
Need clarity.
They need to understand the opportunity, the competitive advantage and the potential for growth.
Need rigor.
They look for evidence, methodology and technical credibility without sacrificing accuracy.
Need alignment.
They need to see where your innovation fits and how collaboration can create strategic value.
Need relevance.
They need to quickly understand the problem you solve and why your solution matters to them.
That is the gap Blenti is built to bridge.
WHAT WE’RE BUILDING
Our practice is being built around strategy, narrative and design for biotech, healthtech and life-science teams.

Stage 01
We define the audiences, positioning and communication priorities that connect your science with the people who can move it forward.

Stage 02
We translate complex platforms, mechanisms and evidence into accurate, compelling stories—without flattening what makes the science valuable.

Stage 03
We turn the strategy into a coherent visual and verbal system across websites, social content and the digital touchpoints your startup needs.
About us
Blenti is a new independent studio taking shape between Buenos Aires, Argentina, and Seville, Spain, at the intersection of biotechnology and strategic communication.
We are building it from two complementary perspectives: firsthand experience in biomedical research and biotech, and professional experience in journalism and communication strategy. Our aim is simple—to preserve the depth of the science while making its value clear to the right audience.
Meet the team
Blenti has not launched its full services yet. We are beginning with a founding pilot designed to test our method, listen to early-stage teams and build our first collaborations with care.

Scientific Strategy
Scientific Strategy
Delfina is a biotechnologist and molecular biologist with 10 years of research experience across academia, biotech startups and the pharmaceutical industry. She specializes in human health biotechnology, regenerative gene therapy for the brain and scientific writing for European research and funding programmes. She brings the scientific perspective to Blenti: understanding the evidence, identifying what is genuinely distinctive and translating technical depth without compromising accuracy.

Communication Strategy
Communication Strategy
Carla is a communication strategist and journalist specialized in translating complex ideas into clear, relevant narratives. She has developed communication strategies and content for companies across biotechnology, innovation and finance, adapting highly technical information for different audiences. At Blenti, she helps science-driven startups communicate the value of their innovation with clarity, credibility and purpose.
Scientific communication for biotech startups
Help shape our first chapter
Tell us what you are building, where your startup is today and what is hardest to communicate.